Wang et al., 2020 - Google Patents
Label-free detection of rare circulating tumor cells by image analysis and machine learningWang et al., 2020
View HTML- Document ID
- 1420164493959479397
- Author
- Wang S
- Zhou Y
- Qin X
- Nair S
- Huang X
- Liu Y
- Publication year
- Publication venue
- Scientific reports
External Links
Snippet
Detection and characterization of rare circulating tumor cells (CTCs) in patients' blood is important for the diagnosis and monitoring of cancer. The traditional way of counting CTCs via fluorescent images requires a series of tedious experimental procedures and often …
- 208000005443 Circulating Neoplastic Cells 0 title abstract description 86
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Electro-optical investigation, e.g. flow cytometers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06K—RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K9/00—Methods or arrangements for reading or recognising printed or written characters or for recognising patterns, e.g. fingerprints
- G06K9/00127—Acquiring and recognising microscopic objects, e.g. biological cells and cellular parts
- G06K9/00147—Matching; Classification
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06K—RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
- G06K9/00—Methods or arrangements for reading or recognising printed or written characters or for recognising patterns, e.g. fingerprints
- G06K9/00127—Acquiring and recognising microscopic objects, e.g. biological cells and cellular parts
- G06K9/0014—Pre-processing, e.g. image segmentation ; Feature extraction
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30024—Cell structures in vitro; Tissue sections in vitro
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
- G01N2015/0065—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials biological, e.g. blood
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | Label-free detection of rare circulating tumor cells by image analysis and machine learning | |
He et al. | A new method for CTC images recognition based on machine learning | |
Matek et al. | Human-level recognition of blast cells in acute myeloid leukaemia with convolutional neural networks | |
Zeune et al. | Deep learning of circulating tumour cells | |
Bychkov et al. | Deep learning based tissue analysis predicts outcome in colorectal cancer | |
Eulenberg et al. | Reconstructing cell cycle and disease progression using deep learning | |
Zahedi et al. | Deep analysis of mitochondria and cell health using machine learning | |
Sheikhzadeh et al. | Automatic labeling of molecular biomarkers of immunohistochemistry images using fully convolutional networks | |
Doan et al. | Leveraging machine vision in cell-based diagnostics to do more with less | |
CN113454733A (en) | Multi-instance learner for prognostic tissue pattern recognition | |
Tayebi et al. | Automated bone marrow cytology using deep learning to generate a histogram of cell types | |
Guo et al. | Circulating tumor cell identification based on deep learning | |
Irshad et al. | Crowdsourcing scoring of immunohistochemistry images: Evaluating performance of the crowd and an automated computational method | |
Aprupe et al. | Robust and accurate quantification of biomarkers of immune cells in lung cancer micro-environment using deep convolutional neural networks | |
Manescu et al. | Detection of acute promyelocytic leukemia in peripheral blood and bone marrow with annotation-free deep learning | |
Lin et al. | Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathology | |
Ciurte et al. | Automatic detection of circulating tumor cells in darkfield microscopic images of unstained blood using boosting techniques | |
Salek et al. | COSMOS: a platform for real-time morphology-based, label-free cell sorting using deep learning | |
Rexhepaj et al. | A texture based pattern recognition approach to distinguish melanoma from non-melanoma cells in histopathological tissue microarray sections | |
Wang et al. | Quick leukocyte nucleus segmentation in leukocyte counting | |
Aguilar-Avelar et al. | High-throughput automated microscopy of circulating tumor cells | |
Piansaddhayanon et al. | Label-free tumor cells classification using deep learning and high-content imaging | |
Shi et al. | Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study | |
Soldati et al. | Microfluidic droplets content classification and analysis through convolutional neural networks in a liquid biopsy workflow | |
Ahonen et al. | A high-content image analysis approach for quantitative measurements of chemosensitivity in patient-derived tumor microtissues |